Net profit of Vivo Bio Tech declined 83.37% to Rs 0.87 crore in the quarter ended September 2025 as against Rs 5.23 crore during the previous quarter ended September 2024. Sales rose 8.89% to Rs 13.11 crore in the quarter ended September 2025 as against Rs 12.04 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales13.1112.04 9 OPM %41.3446.43 - PBDT4.088.16 -50 PBT1.515.87 -74 NP0.875.23 -83 Powered by Capital Market - Live News

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Vivo Bio Tech announced that the 38th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live News

Net profit of Vivo Bio Tech rose 688.24% to Rs 1.34 crore in the quarter ended June 2025 as against Rs 0.17 crore during the previous quarter ended June 2024. Sales rose 23.49% to Rs 12.51 crore in the quarter ended June 2025 as against Rs 10.13 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales12.5110.13 23 OPM %43.8843.14 - PBDT4.122.45 68 PBT1.480.22 573 NP1.340.17 688 Powered by Capital Market - Live News

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live News